Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Change in Cash (2016 - 2025)

Perspective Therapeutics (CATX) has disclosed Change in Cash for 16 consecutive years, with $3.9 million as the latest value for Q4 2025.

  • Quarterly Change in Cash rose 102.35% to $3.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$31.0 million through Dec 2025, down 159.34% year-over-year, with the annual reading at -$31.0 million for FY2025, 159.34% down from the prior year.
  • Change in Cash hit $3.9 million in Q4 2025 for Perspective Therapeutics, up from -$2.1 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $132.9 million in Q1 2024 to a low of -$164.9 million in Q4 2024.
  • Historically, Change in Cash has averaged $1.2 million across 5 years, with a median of -$4.5 million in 2022.
  • Biggest five-year swings in Change in Cash: skyrocketed 7229.81% in 2021 and later crashed 1785.23% in 2024.
  • Year by year, Change in Cash stood at $37.9 million in 2021, then plummeted by 192.1% to -$34.9 million in 2022, then surged by 74.94% to -$8.7 million in 2023, then plummeted by 1785.23% to -$164.9 million in 2024, then surged by 102.35% to $3.9 million in 2025.
  • Business Quant data shows Change in Cash for CATX at $3.9 million in Q4 2025, -$2.1 million in Q3 2025, and -$15.6 million in Q2 2025.